| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -40,0 k € | -107.0% | -19,3 k € | -54.7% | -12,5 k € | +2.7% | -12,8 k € | +25.2% | -17,1 k € | -49.8% | -11,4 k € | -5.9% | -10,8 k € | -250.4% | -3,1 k € | -104.7% | 65,7 k € | +1327.5% | 4,6 k € | -67.0% | 13,9 k € | +469.9% | -3,8 k € | |
| EBITDA | -45,1 k € | -129.2% | -19,7 k € | -53.5% | -12,8 k € | +2.6% | -13,2 k € | +24.7% | -17,5 k € | -48.3% | -11,8 k € | +85.3% | -79,9 k € | -2229.6% | -3,4 k € | -105.3% | 65,3 k € | +1435.4% | 4,3 k € | -68.7% | 13,6 k € | +430.3% | -4,1 k € | |
| Operating profit | -50,0 k € | -119.6% | -22,8 k € | -57.5% | -14,5 k € | +2.3% | -14,8 k € | +25.3% | -19,8 k € | -41.0% | -14,0 k € | +82.9% | -82,3 k € | -1311.1% | -5,8 k € | -109.2% | 63,6 k € | +1395.5% | 4,3 k € | -68.7% | 13,6 k € | +430.3% | -4,1 k € | |
| Profit/loss | 829,7 k € | +4298.9% | -19,8 k € | +86.7% | -148,2 k € | -34.1% | -110,5 k € | +25.8% | -148,8 k € | -108.1% | -71,5 k € | +13.2% | -82,4 k € | +67.3% | -252,3 k € | -1667.9% | -14,3 k € | -507.6% | -2,3 k € | -204.0% | 2,3 k € | +108.7% | -26,0 k € | |
| Equity | -9,2 k € | +98.9% | -838,9 k € | -2.4% | -819,1 k € | -22.1% | -670,9 k € | -19.7% | -560,5 k € | -36.2% | -411,6 k € | -21.0% | -340,1 k € | -32.0% | -257,7 k € | -4709.1% | -5,4 k € | -160.1% | 8,9 k € | -20.9% | 11,3 k € | +25.1% | 9,0 k € | |
| Total assets | 142,1 k € | -7.4% | 153,5 k € | +79.3% | 85,6 k € | +2.8% | 83,3 k € | +13.0% | 73,7 k € | -12.6% | 84,3 k € | -36.6% | 133,1 k € | +5.6% | 126,0 k € | -8.6% | 137,8 k € | -11.4% | 155,5 k € | +281.4% | 40,8 k € | +63.4% | 25,0 k € | |
| Cash | 3,6 k € | -35.6% | 5,6 k € | -69.7% | 18,6 k € | +83.9% | 10,1 k € | +5.6% | 9,6 k € | -55.7% | 21,6 k € | +120.3% | 9,8 k € | -34.3% | 14,9 k € | -78.4% | 69,1 k € | -44.2% | 123,8 k € | +883.6% | 12,6 k € | -20.1% | 15,8 k € | |
| Debts | 151,2 k € | -84.8% | 992,4 k € | +9.7% | 904,7 k € | +19.9% | 754,3 k € | +18.9% | 634,2 k € | +27.9% | 495,9 k € | +4.8% | 473,2 k € | +23.3% | 383,6 k € | +168.0% | 143,1 k € | -2.4% | 146,6 k € | +396.8% | 29,5 k € | +85.1% | 15,9 k € | |
Private limited company · Charleroi · incorporated on 26/02/2013
Private limited company with a balanced profile. Cash position declining (-35.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
EURANDLAB is a Private limited company incorporated in 2013. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Charleroi.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette